David Grambow is a Cardiology physician. OpenAlex indexes 8 publications with 438 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2350 N Lake Dr
Suite 400
Milwaukee, WI 532114528
Telephone
414-271-1633Registry record last updated 12 Jun 2012.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20259 payments
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- GlaxoSmithKline, LLC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81.3%Statin18.1%Rosuvastatin Calcium54%Atorvastatin Calcium35%Pravastatin Sodium10%Simvastatin2%Part D<11 patientsBeta blocker16%Metoprolol Succinate55%Carvedilol19%Metoprolol Tartrate17%Atenolol6%Nebivolol Hcl3%Part D<11 patients+ 20 more classes in this area
Blood & clotting
10.7%Factor Xa inhibitor6.9%Eliquis72%Xarelto29%Part D≥82 patientsP2Y12 inhibitor2.1%Clopidogrel73%Brilinta28%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
7.6%SGLT2 inhibitor5.7%Jardiance91%Farxiga9%Part D<11 patientsPotassium supplement1%Potassium Chloride100%Part D≥22 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Emergent percutaneous cardiopulmonary bypass in patients having cardiovascular collapse in the cardiac catheterization laboratory
The American Journal of Cardiology
1994 - Effect of maximal medical therapy on refractoriness of unstable angina pectoris
The American Journal of Cardiology
1992
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”